skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Meta-Analysis on the Clinical Outcomes With Polypills for Cardiovascular Disease Prevention

The American journal of cardiology, 2023-08, Vol.201, p.211-218 [Peer Reviewed Journal]

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;2023. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.06.001 ;PMID: 37385176

Full text available

Citations Cited by
  • Title:
    Meta-Analysis on the Clinical Outcomes With Polypills for Cardiovascular Disease Prevention
  • Author: Sedhom, Ramy ; Hamed, Mohamed ; Tan, Weiyi ; Mansoor, Hend ; Stoletniy, Liset ; Mamas, Mamas ; Abramov, Dmitry ; Elgendy, Islam Y. ; Elbadawi, Ayman
  • Subjects: Adverse events ; Antihypertensives ; Aspirin ; Bias ; Cardiovascular disease ; Cardiovascular diseases ; Cerebral infarction ; Clinical outcomes ; Clinical trials ; Disease control ; Heart ; Meta-analysis ; Mortality ; Myocardial infarction ; Prevention ; Risk ; Statins ; Therapy
  • Is Part Of: The American journal of cardiology, 2023-08, Vol.201, p.211-218
  • Description: Randomized controlled trials (RCTs) examining the outcomes of “polypill” therapy in cardiovascular disease prevention have yielded mixed results. We performed an electronic search through January 2023 for RCTs that examined the use of polypills for cardiovascular disease primary or secondary prevention. The primary outcome was the incidence of major adverse cardiac and cerebrovascular events (MACCEs). The final analysis included 11 RCTs with 25,389 patients; 12,791 patients were in the polypill arm, and 12,598 patients were in the control arm. The follow-up period ranged from 1 to 5.6 years. Polypill therapy was associated with a lower risk of MACCE (5.8% vs 7.7%; risk ratio [RR] 0.78, 95% confidence interval [CI] 0.67 to 0.91). The reduction of MACCE risk was consistent in both primary and secondary prevention. Polypill therapy was associated with a lower incidence of cardiovascular mortality (2.1% vs 3%; RR 0.69, 95% CI 0.55 to 0.87), myocardial infarction (2.3% vs 3.2%; RR 0.72, 95% CI 0.61 to 0.84) and stroke (0.9% vs 1.6%; RR 0.62, 95% CI 0.42 to 0.90). Polypill therapy was associated with a higher degree of adherence. There was no difference between both groups in the incidence of serious adverse events (16.1% vs 15.9%; RR 1.12, 95% CI 0.93 to 1.36). In conclusion, we found that a polypill strategy was associated with a lower incidence of cardiac events and higher adherence, without an increased incidence of adverse events. This benefit was consistent for both primary and secondary prevention.
  • Publisher: United States: Elsevier Inc
  • Language: English
  • Identifier: ISSN: 0002-9149
    EISSN: 1879-1913
    DOI: 10.1016/j.amjcard.2023.06.001
    PMID: 37385176
  • Source: ProQuest Central
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait